Quarterly report pursuant to Section 13 or 15(d)

Supplemental Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details)

v3.24.2.u1
Supplemental Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued consulting $ 54,298 $ 49,395
Accrued compensation 486,956 635,451
Accrued research and development 1,482,340 1,472,292
Accrued other 10,931 102,817
Total accrued expenses and other current liabilities $ 2,034,525 $ 2,259,955